Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Photodynamic therapy successfully treated skin cancer in a 53-year-old woman.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

Long-term antiandrogen use may increase aggressive prostate cancer risk.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Using finasteride and doxazosina together works better for treating benign prostatic hyperplasia than using just one.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Androgen deprivation therapy might help prevent severe COVID-19, but more research is needed.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

YH0618 granule may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Oral minoxidil may help hair regrowth in female cancer survivors.

Prostaglandins may protect hair follicles during chemotherapy.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Taking dutasteride for one month before prostate surgery can reduce bleeding.